USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 160 filers reported holding USANA HEALTH SCIENCES INC in Q1 2024. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $574,483 | -9.5% | 11,845 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $634,892 | -0.4% | 11,845 | +8.9% | 0.00% | 0.0% |
Q3 2023 | $637,442 | -12.0% | 10,876 | -5.4% | 0.00% | 0.0% |
Q2 2023 | $724,645 | +17.3% | 11,495 | +17.1% | 0.00% | 0.0% |
Q1 2023 | $617,678 | +18.3% | 9,820 | +0.0% | 0.00% | 0.0% |
Q4 2022 | $522,265 | -53.1% | 9,817 | -50.5% | 0.00% | 0.0% |
Q3 2022 | $1,113,000 | -24.3% | 19,850 | -2.3% | 0.00% | -50.0% |
Q2 2022 | $1,470,000 | -25.9% | 20,320 | -18.6% | 0.00% | 0.0% |
Q1 2022 | $1,983,000 | -62.2% | 24,955 | -51.8% | 0.00% | -33.3% |
Q4 2021 | $5,245,000 | +417.8% | 51,825 | +371.5% | 0.00% | +200.0% |
Q3 2021 | $1,013,000 | -34.6% | 10,992 | -27.5% | 0.00% | 0.0% |
Q2 2021 | $1,549,000 | +1.0% | 15,168 | -3.5% | 0.00% | 0.0% |
Q1 2021 | $1,533,000 | +19.7% | 15,714 | -5.5% | 0.00% | 0.0% |
Q4 2020 | $1,281,000 | +60.1% | 16,624 | +53.1% | 0.00% | – |
Q3 2020 | $800,000 | -0.5% | 10,856 | -0.9% | 0.00% | -100.0% |
Q2 2020 | $804,000 | +1.8% | 10,951 | -19.8% | 0.00% | 0.0% |
Q1 2020 | $790,000 | -9.6% | 13,658 | +22.7% | 0.00% | 0.0% |
Q4 2019 | $874,000 | -10.3% | 11,134 | -21.8% | 0.00% | 0.0% |
Q3 2019 | $974,000 | -73.5% | 14,239 | -69.2% | 0.00% | -66.7% |
Q2 2019 | $3,669,000 | -18.3% | 46,196 | -13.7% | 0.00% | -25.0% |
Q1 2019 | $4,489,000 | +46.0% | 53,526 | +105.0% | 0.00% | +33.3% |
Q4 2018 | $3,074,000 | -25.8% | 26,111 | -24.0% | 0.00% | -25.0% |
Q3 2018 | $4,141,000 | +119.9% | 34,346 | +110.4% | 0.00% | +100.0% |
Q2 2018 | $1,883,000 | +41.3% | 16,328 | +5.2% | 0.00% | +100.0% |
Q1 2018 | $1,333,000 | +27.8% | 15,518 | +10.2% | 0.00% | 0.0% |
Q4 2017 | $1,043,000 | +15.5% | 14,087 | -10.0% | 0.00% | 0.0% |
Q3 2017 | $903,000 | +61.0% | 15,652 | +78.5% | 0.00% | 0.0% |
Q2 2017 | $561,000 | -53.1% | 8,771 | -57.7% | 0.00% | 0.0% |
Q1 2017 | $1,195,000 | -9.5% | 20,741 | -3.8% | 0.00% | 0.0% |
Q4 2016 | $1,320,000 | +27.4% | 21,569 | +187.9% | 0.00% | 0.0% |
Q3 2016 | $1,036,000 | -42.7% | 7,493 | -53.8% | 0.00% | -50.0% |
Q2 2016 | $1,808,000 | +34.3% | 16,236 | +46.6% | 0.00% | 0.0% |
Q1 2016 | $1,346,000 | -41.0% | 11,078 | -38.0% | 0.00% | -33.3% |
Q4 2015 | $2,283,000 | +14.9% | 17,863 | +20.5% | 0.00% | +50.0% |
Q3 2015 | $1,987,000 | +115.7% | 14,828 | +120.1% | 0.00% | +100.0% |
Q2 2015 | $921,000 | +10.3% | 6,737 | -10.3% | 0.00% | 0.0% |
Q1 2015 | $835,000 | -72.7% | 7,512 | -74.8% | 0.00% | -66.7% |
Q4 2014 | $3,054,000 | +338.8% | 29,772 | +215.2% | 0.00% | +200.0% |
Q3 2014 | $696,000 | -0.4% | 9,446 | +5.6% | 0.00% | 0.0% |
Q2 2014 | $699,000 | -21.9% | 8,942 | -24.8% | 0.00% | 0.0% |
Q1 2014 | $895,000 | -43.4% | 11,887 | -43.2% | 0.00% | 0.0% |
Q4 2013 | $1,581,000 | +128.5% | 20,925 | +162.4% | 0.00% | 0.0% |
Q3 2013 | $692,000 | -78.2% | 7,973 | -81.8% | 0.00% | -66.7% |
Q2 2013 | $3,176,000 | +319.0% | 43,889 | +180.2% | 0.00% | +200.0% |
Q1 2013 | $758,000 | – | 15,665 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |